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The impact of diabetes on postoperative outcomes
following lower-extremity bypass surgery
Jessica B. Wallaert, MD,a Brian W. Nolan, MD, MS,a Julie Adams, MD,b Andrew C. Stanley, MD,b
Jens Eldrup-Jorgensen, MD,c Jack L. Cronenwett, MD,a and Philip P. Goodney, MD, MS,a Lebanon, NH;
Burlington, Vt; and Portland, Me
Objective: The effect of diabetes type (noninsulin dependent vs insulin dependent) on outcomes after lower-extremity
bypass (LEB) has not been clearly defined. Therefore, we analyzed associations between diabetes type and outcomes after
LEB in patients with critical limb ischemia.
Methods: We performed a retrospective analysis of 1977 infrainguinal LEB operations done for critical limb ischemia
between 2003 and 2010 within the Vascular Study Group of New England. Patients were categorized as nondiabetic
(ND), noninsulin-dependent diabetic (NIDD), or insulin-dependent diabetic (IDD) based on their preoperative
medication regimen. Our main outcome measures were in-hospital mortality and major adverse events (MAEs) – a
composite outcome, including myocardial infarction, dysrhythmia, congestive heart failure, wound infection, renal
insufficiency, and major amputation. We compared crude and adjusted rates of mortality and MAEs using logistic
regression across diabetes categories.
Results:Overall, 41% of patients were ND, 28%were NIDD, and 31%were IDD. Crude rates of in-hospital mortality were
similar across these groups (1.7% vs 3.1% vs 2.1%; P  .211). Adjusted analyses accounting for differences in patient
characteristics showed that diabetes is not associated with increased risk of in-hospital mortality. However, type of
diabetes was associated with a higher risk of MAEs in both crude (15.1% for ND; 21.1% for NIDD; and 25.2% for IDD;
P< .001) and adjusted analyses (odds ratio for NIDD, 1.41; 95% confidence interval, 1.2-1.7; odds ratio for IDD, 1.53;
95% confidence interval, 1.3-1.8).
Conclusions:Diabetes is a significant contributor to the risk of postoperative complications after LEB surgery, and insulin
dependence is associated with higher risk. Quality measures aimed at limiting complications after LEBmay have the most
impact if these initiatives are focused on patients who are IDD. (J Vasc Surg 2012;56:1317-23.)
a
(
e
v
o
l
o
fi
d
o
(
o
t
w
d
M
d
l
d
V
l
o
w
f
pSeveral studies have shown that diabetes is an indepen-
dent risk factor for adverse postoperative outcomes, such as
mortality and surgical site infection, in patients undergoing
a wide range of surgical interventions.1-3 However, the
effect of diabetes on surgical risk among patients undergo-
ing lower-extremity bypass (LEB) surgery remains contro-
versial. Although some have found that patients with dia-
betes undergoing LEB experience increased rates of
amputation, cardiac complications, and infection,4 other
studies have demonstrated that patients with diabetes are
not at increased risk for worse outcomes compared to
patients who are nondiabetic.5,6
We hypothesize that this discrepancy may result from
analytical methods that did not account for the extent or
type of diabetes within the study population. The impact of
diabetes on postoperative outcomes after LEB may vary
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http://dx.doi.org/10.1016/j.jvs.2012.04.011ccording to the type of diabetes, if the extent of diabetes
noninsulin dependent vs insulin dependent) manifests its
ffect differently. Although several prior authors have in-
estigated the impact of type of disease among diabetics on
utcomes after vascular surgery, these evaluations were
imited in scope7 or reported a narrow range of clinical
utcomes.8 Accordingly, the aims of our study were to,
rst, examine the influence of the type of diabetes (as
efined by insulin dependence) on a wide range of clinical
utcomes after LEB in patients with critical limb ischemia
CLI). Second, we sought to define which patient and
perative characteristics were most closely associated with
hese outcomes among noninsulin-dependent patients
ith diabetes alone and patients with insulin-dependent
iabetes.
ETHODS
Subjects and databases. For this report, we analyzed
ata collected by the Vascular Study Group of New Eng-
and, a regional cooperative quality improvement initiative
eveloped in 2002. Further details on the registry used by
ascular Study Group of New England have been pub-
ished previously9 and are available at http://www.vsgne.
rg.
Data were examined from 1977 patients who under-
ent primary LEB for CLI. We studied procedures per-
ormed by 69 participating surgeons across 14 study hos-
itals between January 1, 2003, and June 1, 2010. Because
e were unable to differentiate patients with disabling
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November 20121318 Wallaert et alclaudication in our database from those with less severe
claudication, patients whose indication for bypass surgery
did not include rest pain or tissue loss were excluded from
our analysis.
Our exposure variable was the degree to which the
patients were affected by diabetes. Subjects were divided
into three cohorts based on diabetic status: nondiabetic
(ND), noninsulin-dependent diabetic (NIDD), and insulin-
dependent diabetic (IDD). Insulin dependence was de-
fined as reliance on insulin administration at baseline to
control diabetes. Patients who were diabetic, but did not
rely on insulin, were categorized as noninsulin dependent.
In our study, insulin dependence is not synonymous with
type I diabetes, but rather defines the patient-level pattern
of insulin utilization at the time of LEB.
Outcome measures. Our study had two main out-
come measures: in-hospital mortality and major adverse
events (MAEs) – a composite outcome, including myocar-
dial infarction (MI), congestive heart failure (CHF), dys-
rhythmia, wound infection, renal insufficiency, and major
amputation. Patients experiencing one or more of the
above adverse events were included in the composite out-
come. OnlyMAEs that occurred during the surgical admis-
sion were included in this analysis. MI included both ST-
segment elevation MIs, diagnosed by a change from
baseline electrocardiogram, and non-ST elevation MIs,
diagnosed by elevated cardiac enzymes in the setting of an
electrocardiogram unchanged from baseline. Dysrhythmia
included the presence of any new cardiac rhythm that
was not normal sinus. The diagnosis of postoperative CHF
was left to the discretion of the operating surgeon and was
based primarily on clinical signs and symptoms. The desig-
nation of wound infection was also made on clinical suspi-
cion or data indicative of wound infection (culture positive
or requiring antibiotics). Renal insufficiency was defined as
an increase in plasma creatinine of 0.5 from baseline or
the need for dialysis. Last, major amputation was defined as
amputation occurring below the knee or more proximal.
Outcomes for each strata of patients with diabetes were
compared to the patients who were nondiabetic.
Statistical analysis. First, using data from all patients,
we examined univariate associations between individual
patient characteristics and each of our main outcome mea-
sures. Rates were compared across strata (ND, NIDD, and
IDD) using 2. Differences with P  .05 were considered
to be significant.
Next, multivariable analyses were performed to adjust
for confounding due to baseline risk factors and then to
identify patient-level risk factors associated with in-hospital
death or MAEs after LEB surgery. All variables with uni-
variate significance P .20 were used to develop hierarchi-
cal regression models. Hierarchical models were used to
account for the nonrandom assignment of patients within
hospitals. Backward stepwise logistic regression was used to
create a hierarchical model for death, as well as a separate
model for MAEs. We used nested likelihood ratio tests
while clustering for center-effect. Discrimination for final
models was assessed using the area under the receiver pperating curve (AUC), andmodel calibration was assessed
sing goodness of fit (GOF) testing across strata of patient
isk. Finally, to examine the effect of patient risk within
ach strata of diabetes, we developed models for mortality
nd MAEs within each strata of diabetes (ND, NIDD, and
DD). Statistical significance was defined as P  .05, and
ata were analyzed using Stata 11.0 (StataCorp, College
tation, Tex).
ESULTS
Patient demographics. Baseline patient characteris-
ics, stratified by type of diabetes (ND, NIDD, IDD), are
epresented in Table I.10 Overall, 59% of patients (1161)
ndergoing LEB surgery for CLI were diabetic. Of patients
ith diabetes, 47% were categorized as NIDD. Among
atients who are NIDD, 122 (23%) were described as diet
ontrolled, whereas 419 (77%) relied on oral hypoglyce-
ics. Overall, 620 patients (53% of all patients with diabe-
es, and 31% of the entire cohort) were dependent on
nsulin preoperatively for glucose control.
We found that patients who are IDD had an increased
umber and magnitude of surgical risk factors compared to
oth patients who are ND and NIDD. For example, when
ompared with patients who are ND and NIDD, patients
ho are IDD were significantly more likely than the
ther two groups to have coronary artery disease (CAD;
2.6% ND; 40.3% NIDD; and 50.0% IDD; P  .001),
HF (14.7% ND; 19.8% NIDD; and 31.3% IDD; P 
001), and chronic renal insufficiency (11.2% ND; 15.2%
IDD; and 31.4% IDD; P  .001), pointing out the
eed for risk adjustment when comparing outcomes
cross these groups.
Main outcome measure: In-hospital mortality. In
nivariate analyses, overall in-hospital mortality was 2.2%
n  44 of 1977) after LEB surgery. Crude mortality rates
id not differ for patients who are ND (1.7%), NIDD
3.1%), and IDD (2.1%; P  .211).
In multivariable analysis, studying the effect of type of
iabetes across all patients, after adjustment for differences
n baseline patient characteristics, diabetes, independent of
ype, was not a predictor of mortality. Characteristics that
ere most strongly associated with in-hospital mortality
ncluded age greater than 80 (odds ratio [OR], 2.2; 95%
onfidence interval [CI], 1.2-4.1; P .01), CHF (OR, 3.5;
5% CI, 1.9-6.4; P .001), and tissue loss as the indication
or surgery (OR, 3.3; 95% CI, 1.6-6.9; P .002; Table II).
Within our diabetes type-specific models, we identified
everal patient-level risk factors associated with postopera-
ive mortality. For example, within patients who are IDD,
ndependent risk factors associated with in-hospital mortal-
ty were CHF (OR, 9.1; 95% CI, 2.6-32.7; P  .001),
ypass origin distal to the common femoral artery (CFA;
R, 3.9; 95% CI, 1.2-13.0; P  .025), and lack of great
aphenous vein (GSV) conduit (OR, 2.9; 95% CI, 1.3-6.7;
 .010). Indication for surgery (rest pain vs tissue loss)
as not included in this model because no patients who
ere IDD who were operated on for an indication of rest
ain died during their surgical admission. This predictive
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Volume 56, Number 5 Wallaert et al 1319model had relatively good discrimination (AUC, 0.83) and
calibration (GOF, P .532). Similarly, within patients who
were NIDD, independent predictors of in-hospital mortal-
ity were age 80 (OR, 3.1; 95% CI, 1.1-8.8; P  .028),
CAD (OR, 3.1; 95% CI, 1.5-6.4; P .002), and tissue loss
as the indication for surgery (OR, 3.1; 95%CI, 1.1-8.8; P
.028). Hypertension was protective against mortality in this
cohort of patients (OR, 0.21; 95% CI, 0.1-0.9; P  .030).
This predictive model had modest discrimination (AUC,
Table I. Patient and operative characteristics by diabetes s
ND
n  816
NID
n  5
Patient characteristics
Male, % 67.2 67.5
Age, %
60 years 19.5 16.6
60-80 years 53.7 57.7
80 years 26.8 25.7
Obese, % (BMI 30)a 11.8 20.3
Hypertension, % 81.7 92.2
CAD, % 32.6 40.3
Chronic obstructive pulmonary disease, % 32.5 25.3
Smoking, % 83.8 81.1
CHF, % 14.7 19.8
Chronic renal insufficiency, % (Cr 1.8) 11.2 15.2
Dialysis, % 4.4 7.6
Prior percutaneous intervention, % 10.3 10.5
Ankle brachial index, mean 0.46 0.5
Indication for surgery, %
Rest pain 51.4 30.1
Tissue loss 48.6 69.9
Operative characteristics
General anesthesia, % 77.0 75.0
Common femoral artery inflow, % 66.9 64.9
Conduit, %
Reversed GSV 21.7 23.8
Nonreversed GSV 48.0 44.4
Arm vein 1.8 2.6
Prosthetic 26.1 24.8
BMI, Body mass index; CAD, coronary artery disease; CHF, congestive h
diabetic; ND, nondiabetic; NIDD, noninsulin-dependent diabetic.
aOf note, BMI was not recorded for 468 of 1977 patients (24%) in our analys
BMI in our cohort of 27.2 kg/m2.
Table II. Multivariate models for predicting in-hospital
mortality after LEB surgery in all patients with CLI
Covariates OR 95% CI P value
Age 80 years 2.18 1.17-4.07 .01
CHF 3.53 1.94-6.41 .001
Dialysis dependence 1.79 1.07-2.96 .024
Obesity 0.12 0.04-0.40 .001
Aspirin use 0.57 0.33-0.97 .039
Tissue loss as indication for
surgery 3.28 1.56-6.91 .002
Nonuse of GSV 2.19 1.23-3.90 .001
AUC, 0.8130; GOF, P  .98
AUC, Area under curve; CHF, congestive heart failure; CI, confidence
interval; CLI, critical limb ischemia; GOF, goodness of fit; GSV, great
saphenous vein; LEB, lower-extremity bypass; OR, odds ratio.0.75) and good calibration (GOF, P  .994). MMain outcome measure: Major adverse events.
verall, 19.9% (n  393) of patients experienced an MAE
uring the admission after surgery. In univariate analysis,
rude rates of wound infection before discharge (5.2% ND;
.8% NIDD; and 5.8% IDD) and dysrhythmia (4.4% ND;
.6% NIDD; and 6.5% IDD) did not differ across catego-
ies of diabetes. However, rates of major amputation, MI,
HF, and renal insufficiency were all directly related to the
ype of diabetes (Fig). Finally, overall MAE rates were also
irectly related to the type of diabetes (15.1% ND; 21.1%
IDD; and 25.2% IDD; P  .001).
In multivariable analyses considering the entire cohort,
AE rates revealed a similar diabetic treatment-type rela-
ionship. Patients with NIDD had a higher likelihood of
xperiencing MAEs than did patients who were ND (OR,
.41; 95% CI, 1.1-1.7; P .001), and those with IDD also
xperienced increased risk (OR, 1.53; 95%CI, 1.3-1.8; P
001). Other independent predictors of MAEs included
emale gender, CHF, CAD, estimated glomerular filtration
ate (eGFR) 60, and bypass origin distal to the CFA
Table III). However, this model’s ability to predict MAEs
ad only modest discrimination (AUC, 0.65), likely due to
he use of a composite end point and good calibration
GOF, P  .981).
Finally, we sought to define predictors of postoperative
IDD
n  620
P value
(ND to NIDD)
P value
(ND to IDD)
P value
(ND to IDD)
66.8 .905 .879 .802
.281 .001 .001
23.9
61.1
15.0
24.4 .001 .001 .101
93.9 .001 .001 .313
50.0 .004 .001 .001
30.5 .005 .421 .051
77.8 .196 .004 .169
31.3 .014 .001 .001
31.4 .036 .001 .001
15.7 .014 .001 .001
12.1 .886 .281 .403
0.58 .046 .001 .018
.001 .001 .001
19.5
80.5
79.7 .417 .217 .059
62.7 .439 .101 .450
19.0 .353 .217 .046
44.4 .184 .166 .998
4.0 .350 .012 .173
27.4 .581 .576 .306
ilure; Cr, creatinine; GSV, great saphenous vein; IDD, insulin-dependent
refore, we used imputationmethods10 and assigned these patients the meantatus
D
41
1
eart faAEs among patients within each subclass of diabetes.
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MAEs included CAD (OR, 1.8; 95% CI, 1.3-2.5; P .001),
CHF (OR, 2.5; 95% CI, 1.3-4.6; P  .005), and the use of
GSV conduit (OR, 1.7; 95%CI, 1.2-2.5;P .004;Table IV).
This model demonstrated modest discrimination (AUC,
0.65) and good calibration (GOF, P  .284). Within multi-
variable analysis studying only patients who were IDD, inde-
pendent risk factors associated with MAEs were eGFR 60
(OR, 1.4; 95% CI, 1.1-1.8; P  .002) and CHF (OR, 2.3;
Fig. Crude rates of major adverse events (MAEs) after
status: nondiabetic (ND), noninsulin-dependent diabeti
Table III. Multivariate models for predicting MAEs after
LEB surgery in all patients with CLI
Covariates OR 95% CI P value
Diabetes
ND Referent — —
NIDD 1.41 1.15-1.74 .001
IDD 1.53 1.32-1.78 .001
CHF 2.08 1.47-2.95 .001
CAD 1.36 1.07-1.73 .012
eGFR 60 1.40 1.10-1.77 .006
Female gender 1.22 1.08-1.39 .001
Inflow distal to the CFA 1.32 1.09-1.61 .005
AUC, 0.6462
AUC, Area under curve; CAD, coronary artery disease; CFA, common
femoral artery; CHF, congestive heart failure; CI, confidence interval; CLI,
critical limb ischemia; eGFR, estimated glomerular filtration rate; IDD,
insulin-dependent diabetic; LEB, lower-extremity bypass; MAEs, major ad-
verse events;ND, nondiabetic;NIDD, noninsulin-dependent diabetic; OR,
odds ratio.95% CI, 1.5-3.6; P  .001; Table IV). As with previous Lodels for MAEs, this model demonstrated modest discrim-
nation (AUC, 0.61) and good calibration (GOF, P .321).
ISCUSSION
Impact of diabetes on outcomes after vascular
urgery. The relative impact of diabetes on postoperative
utcomes after vascular surgery remains controversial,4-7
ith several studies demonstrating increased risk of
erioperative morbidity4 and mortality11 among diabet-
cs, whereas others report no added risk in this population
f patients.6,12 In 2004, Virkkunen et al4 studied 5709
ypass surgeries performed for an indication of CLI and
ound that, after adjustment for differences in baseline
omorbidities, patients with diabetes had increased risk of
elow-knee amputation (OR, 1.7), cardiac complications
OR, 1.5), and wound infection (OR, 1.3) compared to
atients who were ND. Similarly, Luther et al11 reported
igher rates of perioperative mortality (14% vs 1%) and
orse 5-year survival (42% vs 71%) among patients with
iabetes compared to those without diabetes undergoing
emorotibial reconstruction for CLI. Further, Roghi et al13
ound that diabetes was an independent predictor for major
ardiac events (OR, 2.5) among intermediate-risk patients
ndergoing vascular surgery, including LEB.
However, others have reported evidence to the con-
rary, including Akbari et al,6 who demonstrated reduced
n-hospital mortality in patients with diabetes compared to
ondiabetics (0.9% vs 4.2%) and reported no difference
etween the groups in 5-year survival or limb salvage.
-extremity bypass surgery, stratified by patient diabetes
DD), and insulin-dependent diabetic (IDD).lowerikewise, Hamdan et al12 reported that diabetes is protec-
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Volume 56, Number 5 Wallaert et al 1321tive against perioperativemortality (OR, 0.55) and is not an
independent predictor of MI after lower-extremity revas-
cularization.
Critical review of previous studies suggests that there
may be room to better define the impact of diabetes on
outcomes after LEB. First, previous studies made little
attempts to control for differences in baseline patient and
operative characteristics.6 Second, some of the studies were
limited in sample size and had low event rates,13 and most
studies aggregated multiple types of vascular surgery as a
combined entity.13
Our study, derived from a large sample of generalizable
data from real-world vascular practice, limits the analysis to
a cohort of patients undergoing LEB for CLI, and provides
information pertaining to a wide range of clinically impor-
tant outcomes. Further, although we found that diabetics
on the whole suffer from increased rates of several postop-
erative complications, we also examined the impact of the
type of diabetes on postoperative outcomes after LEB and
found that this stratification offers additional important
information.
Impact of type of diabetes on outcomes after vascu-
lar surgery. Although few prior studies have examined the
impact of type of diabetes (determined by the need for
home insulin) on outcomes in patients undergoing all types
of vascular surgery, those studies which have been pub-
lished on this topic have differed in their conclusions. For
example, in 2002, Axelrod et al8 published a study per-
formed in a veteran population showing that IDD is a
significant predictor of increased risk for cardiovascular
events after vascular surgery (adjusted OR, 1.5; 95% CI,
1.5-1.9). However, this study did not find significant
associations between diabetes and postoperative mortal-
ity or NIDD and other adverse postoperative outcomes.
These results differ from ours which suggest that patients
who were NIDD fair significantly worse than their non-
diabetic counterparts, both with regard to rates of in-
hospital mortality and other MAEs.
Other studies have reached similar conclusions to ours.
In 2007, Hertzer et al7 also examined outcomes stratified
by type of diabetes after LEB. In this descriptive analysis of
over 600 LEB procedures performed by a single surgeon
over a 16-year period, postoperative complications among
Table IV. Multivariate models for predicting MAEs after
Covariates
NIDDs
OR 95% CI
CAD 1.76 1.26-2.46
CHF 2.46 1.31-4.61
eGFR 60 — —
Use of GSV conduit 1.70 1.18-2.45
AUC 0.6482
AUC, Area under curve; CAD, coronary artery disease; CHF, congestive he
glomerular filtration rate; GSV, great saphenous vein; IDDs, insulin-depend
noninsulin-dependent diabetics; OR, odds ratio.patients with diabetes are similar to those presented in our series. However, Hertzer et al7 also examined long-term
utcomes and demonstrated significantly higher rates of 1-
nd 5-year mortality among both patients who were NIDD
OR, 1.4; 95% CI, 1.1-1.8) and patients who were IDD
OR, 1.5; 95% CI, 1.2-1.8). This study also showed that
DD is a significant predictor of both short-term and
ong-term amputation.
The impact of severity of diabetes has been examined
ore extensively in cardiac surgery patients, with findings
imilar to ours. For example, Carson et al14 examined the
mpact of type of diabetes on outcomes after coronary
rtery bypass graft (CABG) in over 140,000 patients and
emonstrated a clear dose-response curve with risk of in-
ection (deep sternal, leg, septicemia, urinary tract infec-
ion, or pneumonia) significantly higher among patients
ho were NIDD than those who were ND (adjusted OR,
.24) and even higher among patients who were IDD (OR,
.55). Another study, by Zacharias et al,15 reports IDD as
n independent predictor of sternal wound infection (OR,
.9) after CABG or combined CABG/valve surgery. Sim-
lar studies have shown insulin dependence portrays in-
reased risk of perioperative mortality16 and longer length
f stay17 compared to NIDD.
Our findings add important context to this literature in
wo ways. First, although prior studies reporting outcomes
mong diabetics after LEB offer a single surgeon’s experi-
nce,7 the data presented here provide the perspective of a
argemulticenter experience, representing 14 academic and
ommunity hospitals and nearly 70 surgeons’ experiences,
hich may make the findings more generalizable. Second,
ithin our regional quality improvement collaborative, this
tudy served to provoke interest and focus direction toward
mproving the care of patients with diabetes undergoing
EB. As described in previous work,9 our regional collab-
rative collects data across a broad spectrum of clinical
etail in a prospective fashion and reviews this data at
iannual meetings. These real-time findings regarding the
isks involved for patients with diabetes were of interest to
everal in our region who participate in quality improve-
ent activities, and served to motivate several initiatives
oward improving outcomes for patients with diabetes.
herefore, this work demonstrates the utility of our dataset
ot only for descriptive analyses of the current circum-
surgery in NIDDs and IDDs with CLI
IDDs
P value OR 95% CI P value
.001 — — —
.005 2.31 1.48-3.62 .001
— 1.40 1.13-1.75 .002
.004 — — —
0.6124
ilure; CI, confidence interval; CLI, critical limb ischemia; eGFR, estimated
betics; LEB, lower-extremity bypass;MAEs, major adverse events; NIDDs,LEB
art fatances surrounding clinically important measures, but also
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largest opportunities for meaningful change.
One additional finding that warrants discussion is the
effect of using GSV in those patients with NIDD. In nearly
every major article, the use of conduit other than GSV is
associated with poorer outcomes. In our study, although
this relationship holds true for patients who are IDD, we
found among patients who are NIDD, the direction of the
effect is reversed (OR, 1.6), with a very wide CI (1.04-
2.47). We believe the explanation behind these competing
associations is likely multifactorial— a relatively small num-
ber of diverse MAEs in the subgroups by insulin type,
selection for use of GSV in patients with tissue loss, the
need for crural bypass, and the fact that these data represent
only short-term outcomes are three of the most likely
explanations.
Improving outcomes among diabetics undergoing
LEB. We and others have found that patients who are
IDD have significantly higher rates of postoperative com-
plications than their ND counterparts,7,8 and our study
suggests that these risks are present, to a lesser degree, in
patients who are NIDD as well. This relationship provides
the framework for designing quality improvement initia-
tives aimed at improving the care that we provide for
patients undergoing LEB, indicating that initial efforts
should focus largely on patients who are IDD. Therefore,
our future work will aim to examine the impact of various
measures for improving and standardizing themanagement
of patients with diabetes postoperatively in an effort to
reduce postoperative complications. Specifically, at our
center and others in our region, we are examining the
impact of insulin administration protocols (both intermit-
tent and continuous) and the utility of a glucose manage-
ment service on glycemic control and outcomes after LEB.
Preliminary results indicate that both interventions result in
significant improvements in glucose management com-
pared to previous standards of care18 and will serve for a
larger, multicenter trial aimed at improving the quality of
care we provide diabetics undergoing vascular surgery.
Study limitations. Our study has several limitations.
First, the MAEs reported only account for events occurring
during a patient’s surgical admission and do not reflect
30-day or longer-term outcomes. This limitation is likely
the reason our study failed to identify statistically significant
differences in some of the independent adverse events that
are more likely to occur after a patient’s discharge from the
hospital, such as wound infection and amputation. How-
ever, we have established that patients with diabetes are at
increased risk for many complications in the immediate
postoperative period and suspect these trends would persist
at follow-up as well. Second, because additional measures
of diabetes disease severity, such as HA1C and actual
glucose values, were not available for this study, the use of
insulin was used as a surrogate for disease severity. How-
ever, we recognize that not all patients who are IDD have
more severe disease than patients who are NIDD, and there
is an associated potential for confounding by extent of
medical therapy. Further, data pertaining to other poten- Fially important variables that may impact the risk of adverse
ostoperative outcomes, such as the presence of a preoper-
tive infection or anemia, and details regarding outflow
ere not available in the database. Third, the use of a
omposite outcome (MAEs) limits the predictive ability of
ur multivariable model because each included adverse
vent is likely to have different independent predictors.
owever, we chose to use a combined end point to increase
he power of the analysis and to include all clinically impor-
ant outcomes in our study, as this end point incorporates a
ariety of outcomes valuable to clinicians who care for
iabetics after LEB. Fourth, the impact of diabetes on
utcomes after LEB may be attenuated in our analysis due
o the fact that our multivariable models adjusted for
onditions that may be the result of poorly controlled
iabetes, and therefore mediate the relationship between
iabetes and outcomes, rather than being independent of
hese relationships. Likewise, there are undeniably unmea-
ured confounders that are unaccounted for in this analysis.
ifth, this analysis does not account for multiple compari-
ons for two reasons. First, whereas this is a single study
valuating more than one hypothesis, each hypothesis is
ested using a single test and many logistic regression
odels have previously been published without accounting
or multiple comparisons. Further, given the relatively low
vent rates in our analysis, the risk of a type II error for some
utcomes is not negligible and therefore further increasing
his risk by lowering the alpha is not ideal. Finally, while the
dvantages of reporting prospective data from multiple
enters are obvious, the disadvantage to this approach lies
n the inherent variation in both the management of pa-
ients with diabetes and the rates of complications across
ndividual centers. While our models used hierarchical
ethods to account for this center-specific effect (patients
nested” within centers), our future efforts will aim to limit
ariation and better standardize both diabetic care and
iabetic care measurement (such as the time and frequency
f blood glucose measurement) across centers in our col-
aborative.
ONCLUSIONS
Although only NIDD seems to have a significant im-
act on short-term mortality after LEB surgery, all patients
ith diabetes are at increased risk for other major postop-
rative complications such as cardiovascular events, ampu-
ation, renal insufficiency, and wound infection. The im-
act of diabetes on many of these outcomes is greatest
mong IDDs. Future work is needed to identify best prac-
ices for managing diabetics in the postoperative period,
nd these efforts should begin by focusing on IDDs.
UTHOR CONTRIBUTIONS
onception and design: JW, BN, JC, PG
nalysis and interpretation: JW, BN, PG
ata collection: JW, BN, JA, AS, JJ, JC, PG
riting the article: JW, BN, PG
ritical revision of the article: JW, BN, JA, AS, JJ, JC, PG
inal approval of the article: JW, BN, JA, AS, JJ, JC, PG
11
1
1
1
1
1
1
1
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 5 Wallaert et al 1323Statistical analysis: JW, BN, PG
Obtained funding: Not applicable
Overall responsibility: JW, BN, PG
REFERENCES
1. Ata A, Valerian BT, Lee EC, Bestle SL, Elmendorf SL, Stain SC. The
effect of diabetes mellitus on surgical site infections after colorectal and
noncolorectal general surgical operations. Am Surg 2010;76:697-702.
2. Bower WF, Jin L, Underwood MJ, Lee JF, Lee KF, Lam YH, et al.
Overt diabetes mellitus adversely affects surgical outcomes of noncar-
diovascular patients. Surgery 2010;147:670-5.
3. Bucerius J, Gummert JF, Walther T, Doll N, Falk V, Onnasch JF, et al.
Impact of diabetes mellitus on cardiac surgery outcome. Thorac Car-
diovasc Surg 2003;51:11-6. [Erratum in Thorac Cardiovasc Surg 2003;
51:113.]
4. Virkkunen J, Heikkinen M, Lepäntalo M, Metsänoja R, Salenius JP,
Finnvasc Study Group. Diabetes as an independent risk factor for early
postoperative complications in critical limb ischemia. J Vasc Surg 2004;
40:761-7.
5. Awad S, Karkos CD, Serrachino-Inglott F, Cooper NJ, Butterfield JS,
Ashleigh R, et al. The impact of diabetes on current revascularisation
practice and clinical outcome in patients with critical lower limb isch-
aemia. Eur J Vasc Endovasc Surg 2006;32:51-9.
6. Akbari CM, Pomposelli FB Jr, Gibbons GW, Campbell DR, Pulling
MC, Mydlarz D, et al. Lower extremity revascularization in diabetes:
late observations. Arch Surg 2000;135:452-6.
7. Hertzer NR, Bena JF, Karafa MT. A personal experience with the
influence of diabetes and other factors on the outcome of infrainguinal
bypass grafts for occlusive disease. J Vasc Surg 2007;46:271-9. [Erra-
tum in J Vasc Surg 2007;46:828-32.]
8. Axelrod DA, Upchurch GR Jr, DeMonner S, Stanley JC, Khuri S, Daley
J, et al. Perioperative cardiovascular risk stratification of patients with
diabetes who undergo elective major vascular surgery. J Vasc Surg
2002;35:894-901. S9. Cronenwett JL, Likosky DS, Russell MT, Eldrup-Jorgensen J, Stanley
AC, Nolan BW, et al. A regional registry for quality assurance and
improvement: The Vascular Study Group of Northern New England
(VSGNNE). J Vasc Surg 2007;46:1093-101; discussion: 1101-2.
0. Little RJA, Rubin DB. Statistical analysis with missing data. Hoboken,
NJ: Wiley; 2002.
1. Luther M, Lepäntalo M. Femorotibial reconstructions for chronic
critical leg ischaemia: influence on outcome by diabetes, gender and
age. Eur J Vasc Endovasc Surg 1997;13:569-77.
2. Hamdan AD, Saltzberg SS, Sheahan M, Froelich J, Akbari CM, Camp-
bell DR, et al. Lack of association of diabetes with increased postoper-
ative mortality and cardiac morbidity: results of 6565 major vascular
operations. Arch Surg 2002;137:417-21.
3. Roghi A, Palmieri B, Crivellaro W, Faletra F, Puttini M. Relationship of
unrecognised myocardial infarction, diabetes mellitus and type of sur-
gery to postoperative cardiac outcomes in vascular surgery. Eur J Vasc
Endovasc Surg 2001;21:9-16.
4. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH.
Diabetes mellitus increases short-term mortality and morbidity in pa-
tients undergoing coronary artery bypass graft surgery. J Am Coll
Cardiol 2002;40:418-23.
5. Zacharias A, Habib RH. Factors predisposing to median sternotomy
complications. Deep vs superficial infection. Chest 1996;110:1173-8.
6. Alserius T, Hammar N, Nordqvist T, Ivert T. Risk of death or acute
myocardial infarction 10 years after coronary artery bypass surgery in
relation to type of diabetes. Am Heart J 2006;152:599-605.
7. Deaton C, Thourani V. Patients with type 2 diabetes undergoing
coronary artery bypass graft surgery: predictors of outcomes. Eur J Car-
diovasc Nurs 2009;8:48-56.
8. Hirashima F, Patel R, Adams JE, Callas PW, Bertges DJ, Steinthorsson
G, et al. Use of a postoperative insulin protocol decreases wound
infection in diabetics undergoing lower extremity bypass. New England
Society for Vascular Surgery Annual meeting 2011. Providence, RI
2011.ubmitted Dec 15, 2011; accepted Apr 4, 2012.
